A study recently published in the concluded that taking pre-exposure propyhlaxis for the prevention of HIV was as safe as aspirin.
Researchers from the University of California, Los Angeles compared five major studies on PrEP for HIV infection and two major studies on aspirin safety.
The study was conducted and written by Noah Kojima, a second year medical student at the David Geffen School of Medicine at UCLA, and Dr. Jeffrey Klausner, professor of medicine in the division of infectious diseases at the David Geffen School of Medicine at UCLA and of public health at the UCLA Fielding School of Public Health.